These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 34512843)

  • 1. COVID-19 vaccines and vaccination: how prepared is Africa?
    Ariyo OE; Oladipo EK; Osasona OG; Obe O; Olomojobi F
    Pan Afr Med J; 2021; 39():107. PubMed ID: 34512843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?
    Cooper S; van Rooyen H; Wiysonge CS
    Expert Rev Vaccines; 2021 Aug; 20(8):921-933. PubMed ID: 34252336
    [No Abstract]   [Full Text] [Related]  

  • 3. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.
    Moodley K; Blockman M; Pienaar D; Hawkridge AJ; Meintjes J; Davies MA; London L
    S Afr Med J; 2021 Mar; 111(6):554-558. PubMed ID: 34382565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
    Massinga Loembé M; Nkengasong JN
    Immunity; 2021 Jul; 54(7):1353-1362. PubMed ID: 34260880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context.
    Afolabi AA; Ilesanmi OS
    Pan Afr Med J; 2021; 38():3. PubMed ID: 33520072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic and vaccination build herd immunity.
    Redwan EM
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):577-579. PubMed ID: 33577008
    [No Abstract]   [Full Text] [Related]  

  • 7. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    Voigt A; Omholt S; Almaas E
    PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranking the relative importance of COVID-19 vaccination strategies in Canada: a priority-setting exercise.
    Zhao L; Ismail SJ; Tunis MC
    CMAJ Open; 2021; 9(3):E848-E854. PubMed ID: 34493551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X
    Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
    Rogers AB; Barrie MB; Fallah MP; Kelly JD
    Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morocco achieves the highest COVID-19 vaccine rates in Africa in the first phase: what are reasons for its success?
    Drissi Bourhanbour A; Ouchetto O
    J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33748858
    [No Abstract]   [Full Text] [Related]  

  • 18. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.
    Otu A; Osifo-Dawodu E; Atuhebwe P; Agogo E; Ebenso B
    Lancet Microbe; 2021 Aug; 2(8):e347-e348. PubMed ID: 34179857
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine nationalism and the dynamics and control of SARS-CoV-2.
    Wagner CE; Saad-Roy CM; Morris SE; Baker RE; Mina MJ; Farrar J; Holmes EC; Pybus OG; Graham AL; Emanuel EJ; Levin SA; Metcalf CJE; Grenfell BT
    Science; 2021 Sep; 373(6562):eabj7364. PubMed ID: 34404735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.